CHRW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Given the investor's beginner level, long-term strategy, and available capital, CHRW is not a strong buy at this moment. The technical indicators are neutral to slightly bearish, insider selling is significant, and the financial performance shows declining revenue and net income. While analysts remain optimistic about the company's recovery and innovation, the lack of immediate positive signals and the current price trend do not justify an entry point for a long-term investor seeking stability.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 36.019, and moving averages are converging, showing no clear trend. The stock is trading near its support level of 166.781, with resistance at 170.53.
Analysts have raised price targets, with many maintaining positive or buy ratings.
Recognition as an innovative company in the supply chain sector.
Productivity gains and cost reductions through automation.
Insiders are selling heavily, with a 1551.76% increase in selling activity over the last month.
Financials show declining revenue (-6.50% YoY) and net income (-8.70% YoY) in Q4
The broader market (S&P
is down 1.79%, reflecting a bearish sentiment.
In Q4 2025, revenue dropped by 6.50% YoY to $3.91 billion, net income declined by 8.70% YoY to $136.32 million, and EPS decreased by 8.20% YoY to $1.12. Gross margin improved slightly to 16.79%, up 2.63% YoY.
Analysts are generally optimistic, with multiple firms raising price targets (ranging from $180 to $225) and maintaining positive or buy ratings. However, one firm (Morgan Stanley) remains underweight, citing concerns about sustainability and cycle pressures.
